HIF1A and cancer: The elevated expression level of HIF-1α has been observed in various primary and secondary malignant tumors, making it a valuable biomarker and potential target for clinical diagnosis, targeted treatment, and prognosis evaluation in numerous diseases (Semenza, 2012; Zeng et al., 2014; Tuomisto et al., 2016).